XML 16 R5.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements Changes in Convertible Preferred Stock and Stockholders' Deficit - USD ($)
$ in Thousands
Series A convertible preferred stock
Series B convertible preferred stock
Common Stock
Additional Paid-in Capital
Accumulated comprehensive income
Accumulated Deficit
Total
Beginning Balance at Dec. 31, 2020 $ 45,652 $ 47,068          
Beginning Balance (in shares) at Dec. 31, 2020 24,302,472 23,440,514          
Increase (Decrease) in Temporary Equity [Roll Forward]              
Issuance of convertible preferred stock net of issuance cost   $ 47,356          
Issuance of convertible preferred stock net of issuance cost (in shares)   23,440,514          
Ending Balance at Mar. 31, 2021 $ 45,652 $ 94,424          
Ending Balance (in shares) at Mar. 31, 2021 24,302,472 46,881,028          
Beginning Balance at Dec. 31, 2020       $ 2,843   $ (44,958) $ (42,115)
Beginning Balance (in shares) at Dec. 31, 2020     2,053,070        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock based compensation       471     471
Stock option exercise       139     139
Stock option exercise (in shares)     70,663        
Net loss           (7,212) (7,212)
Ending Balance at Mar. 31, 2021       3,453   (52,170) $ (48,717)
Ending Balance (in shares) at Mar. 31, 2021     2,123,733        
Ending Balance (in shares) at Mar. 31, 2022             0
Beginning Balance at Dec. 31, 2021     $ 3 231,902 $ 34 (84,728) $ 147,211
Beginning Balance (in shares) at Dec. 31, 2021     24,455,390        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock based compensation       1,107     1,107
Stock option exercise       6     $ 6
Stock option exercise (in shares)     3,160       713
Net loss           (13,036) $ (13,036)
Other comprehensive loss         30   30
Ending Balance at Mar. 31, 2022     $ 3 $ 233,015 $ 64 $ (97,764) $ 135,318
Ending Balance (in shares) at Mar. 31, 2022     24,458,550